Bruce Edward Markham
Fondatore presso Phrixus Pharmaceuticals, Inc.
Profilo
Bruce Edward Markham is the founder of Phrixus Pharmaceuticals, Inc., which was founded in 2006.
He holds the title of Director & Chief Scientific Officer at Phrixus Pharmaceuticals, Inc. from 2012.
Currently, Dr. Markham is the President, Chief Executive Officer & Director at Diapin Therapeutics LLC.
He was formerly an Associate Professor at The Medical College of Wisconsin, Inc. Dr. Markham obtained a doctorate degree from Michigan State University and an undergraduate degree from Western Michigan University.
Posizioni attive di Bruce Edward Markham
| Società | Posizione | Inizio |
|---|---|---|
Phrixus Pharmaceuticals, Inc.
 Phrixus Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Phrixus Pharmaceuticals, Inc. develops Carmeseal for DMD and for acute decompensated heart failure. It is repurposing Poloxamer for heart failure for which the only cure is heart transplantation. The company was founded by Thomas A. Collet and Bruce Markham in 2006 and is headquartered in Ann Arbor, MI. | Fondatore | 16/12/2009 |
Diapin Therapeutics LLC
 Diapin Therapeutics LLC BiotechnologyHealth Technology Diapin Therapeutics LLC operates as a pre-seed, preclinical development-staged company .The company was founded by Yuqing Chen in 2011 and is headquartered in Ann Arbor, MI. | Amministratore Delegato | - |
Precedenti posizioni note di Bruce Edward Markham
| Società | Posizione | Fine |
|---|---|---|
| The Medical College of Wisconsin, Inc. | Corporate Officer/Principal | - |
Formazione di Bruce Edward Markham
| Michigan State University | Doctorate Degree |
| Western Michigan University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Phrixus Pharmaceuticals, Inc.
Phrixus Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Phrixus Pharmaceuticals, Inc. develops Carmeseal for DMD and for acute decompensated heart failure. It is repurposing Poloxamer for heart failure for which the only cure is heart transplantation. The company was founded by Thomas A. Collet and Bruce Markham in 2006 and is headquartered in Ann Arbor, MI. | Health Technology |
Diapin Therapeutics LLC
Diapin Therapeutics LLC BiotechnologyHealth Technology Diapin Therapeutics LLC operates as a pre-seed, preclinical development-staged company .The company was founded by Yuqing Chen in 2011 and is headquartered in Ann Arbor, MI. | Health Technology |
- Borsa valori
- Insiders
- Bruce Edward Markham
